{"nct_id":"NCT01877226","title":"Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants","status":"COMPLETED","status_verified_date":"2013-06","start_date":"2008-09","start_date_type":null,"primary_completion_date":"2008-10","primary_completion_date_type":"ACTUAL","completion_date":"2008-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}